These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11896322)

  • 1. Potential role for rFVIIa in transfusion medicine.
    Hedner U; Erhardtsen E
    Transfusion; 2002 Jan; 42(1):114-24. PubMed ID: 11896322
    [No Abstract]   [Full Text] [Related]  

  • 2. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
    Moltzan CJ; Anderson DA; Callum J; Fremes S; Hume H; Mazer CD; Poon MC; Rivard G; Rizoli S; Robinson S
    Transfus Med; 2008 Apr; 18(2):112-20. PubMed ID: 18399845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
    Mathew P; Young G
    Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery.
    Livnat T; Shenkman B; Spectre G; Tamarin I; Dardik R; Israeli A; Rivkind A; Shabtai M; Marinowitz U; Salomon O
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):379-87. PubMed ID: 22527290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant factor VIIa: a review on its clinical use.
    Franchini M
    Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caution with the published database reviews analyzing the off-label use of recombinant activated factor VII (rFVIIa) in cardiac surgery.
    Al-Ruzzeh S; Navia JL
    Transfus Apher Sci; 2010 Oct; 43(2):245-6. PubMed ID: 20675193
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
    Croom KF; McCormack PL
    BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VII.
    Franchini M; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Lippi G
    Semin Thromb Hemost; 2009 Nov; 35(8):814-9. PubMed ID: 20169518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005011. PubMed ID: 22419303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the management of bleeding disorders.
    Escolar G
    Drug News Perspect; 2004 May; 17(4):285-8. PubMed ID: 15334177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of high dose factor VIIa in hemophilia patients.
    Hedner U
    Adv Exp Med Biol; 2001; 489():75-88. PubMed ID: 11554593
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion medicine service policies for recombinant factor VIIa administration.
    Goodnough LT; Lublin DM; Zhang L; Despotis G; Eby C
    Transfusion; 2004 Sep; 44(9):1325-31. PubMed ID: 15318856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Levi M; Friederich PW; van der Meer J
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2534-7. PubMed ID: 12532665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
    Mohr AM; Holcomb JB; Dutton RP; Duranteau J
    Crit Care; 2005; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
    Canatan D; Eren E; Ozgüner IF; Duman H; Eren C; Büyükyavuz I; Savaş C
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):375-6. PubMed ID: 17473581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences with recombinant factor VIIa in haemophiliacs.
    Hedner U
    Curr Stud Hematol Blood Transfus; 1991; (58):63-8. PubMed ID: 1954776
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review.
    Mathew P
    Thromb Haemost; 2004 Oct; 92(4):738-46. PubMed ID: 15467904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.